Top Eminent Healthcare Group (HKG:6877) expects an attributable profit of HK$1 million for the six months ended June 30, compared with an attributable loss of HK$2.2 million a year prior.
The company attributed the forecast to revenue growth in its core healthcare business, according to a Friday Hong Kong bourse filing.
Separately, the company received letters from legal representatives of Banclogix claiming a certain amount of legal costs under litigation proceedings.
The company said it did not agree on the amount and the final costs payable by the company will have to be determined by the relevant court.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments